Metraipolis › archive › dc_ee6ab56afaa7

Role of FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in a Patient With T/Myeloid Acute Leukemia With an FLT3 Mutation — Europe PMC PMID:42028519

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42028519
DOI
10.7759/cureus.105695
License (as archived)
solo-consultazione
Archived
2026-11-04T01:50:35.823Z
SHA-256 of the archived text
501f0339f2e0a3fd3db17da00dd658d5a67e47bf84a860a121098e26737bdd75
Stable URL of this page
https://metraipolis.com/documento/dc_ee6ab56afaa7

How to cite

Role of FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in a Patient With T/Myeloid Acute Leukemia With an FLT3 Mutation — Europe PMC PMID:42028519 — Europe PMC (en), https://europepmc.org/article/MED/42028519 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee6ab56afaa7 (Metraipolis archive dc_ee6ab56afaa7, sha256 501f0339f2e0a3fd3db17da00dd658d5a67e47bf84a860a121098e26737bdd75)
BibTeX
@misc{dcee6ab56afaa7,
  title = {Role of FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in a Patient With T/Myeloid Acute Leukemia With an FLT3 Mutation — Europe PMC PMID:42028519},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42028519},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee6ab56afaa7; sha256 501f0339f2e0a3fd3db17da00dd658d5a67e47bf84a860a121098e26737bdd75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42028519. Agents can read the archived copy with the MCP tool read_document.